Skip to main content
Student homeVideo home
View Video
1 of 50

Can a proven cancer drug be reimagined to fight brain tumors in kids? | Breakthroughs Can't Wait

As an ACS-IMPACT Research Scholar at the University of Maryland, Baltimore, Gabrielle Olibris spent her summer in the lab of Aditi Banerjee, PhD, targeting medulloblastoma, a pediatric brain cancer, with a novel therapeutic compound called BNPP-433.3 Beta.BNPP-433.3 Beta shows strong potential, she said, explaining, “This is already patented, so it’s a drug that’s already being used to treat prostate cancer.”By exploring a new use for an existing cancer drug, Olibris hopes to help advance research that could lead to safer, more effective treatments for children.#breakthroughscantwaitumb #cancerresearch

More from Youtube

1-6 of 50
Loading...